Biogen Announces Intent to Spin off Its Hemophilia Business

Go back to Biogen Announces Intent to Spin off Its Hemophilia Business
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 209.23 --0 (-0%)
Previous Close $209.23    52 Week High $333.65 
Open $209.23    52 Week Low $223.02 
Day High $209.23    P/E 26.79 
Day Low $209.23    EPS $7.81 
Volume 10